Latest News

Teva Pharmaceutical Industries NYSE: TEVA CEO Richard Francis said the company has progressed from the initial phase of its “Pivot to Growth” plan into its next stage, citing momentum in branded medic

Fractyl Health, Inc. (GUTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

CG Oncology, Inc. (CGON) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Satya Nadella urged the AI industry to prioritize safety and maintain human control over technology. The Microsoft CEO supports third-party AI testing amid industry debate over development pace.

Incoming Mastercard Chief Financial Officer Ling Hai, who assumed that role Aug. 3, outlined a growth-focused capital allocation strategy that includes frontline sales, targeted acquisition and infras

Future crop protection company will be a strongly capitalized market leader with compelling value proposition for farmers, shareholders INDIANAPOLIS, Sept. 14, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE

United Therapeutics Corporation (UTHR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call Transcript

Denali Therapeutics Inc. (DNLI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Cellebrite DI Ltd. (CLBT) Discusses Leadership Transition and Strategic Focus on Growth and Execution Transcript

Zymeworks Inc. (ZYME) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Radiant Logistics, Inc. (RLGT) Q4 2026 Earnings Call Transcript

East West Bancorp, Inc. (EWBC) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

Dutch startup Euclyd, which is a building a chip for AI inference that seeks to rival Nvidia, has raised $230 million funding round. The round was co-led by Samsung, Somerset Capital Partners, the Sca

Dave & Buster's Entertainment NASDAQ: PLAY reported lower second-quarter revenue and earnings but said same-store sales trends improved during July and the early weeks of its third quarter as the comp

CRISPR Therapeutics NASDAQ: CRSP CEO Sam Kulkarni outlined the company's commercial and clinical priorities during a Morgan Stanley discussion, highlighting continued adoption of CASGEVY and expected

Patmos CEO John Johnson argues the U.S. must decentralize AI infrastructure beyond Silicon Valley to compete with China and prevent a dangerous concentration of power.

Jamie Dimon compares regulations to "barnacles on a boat" in a new Treasury Department video featuring top CEOs praising President Trump's pro-growth agenda.

Alliance Entertainment Holding Corporation is rated a Buy due to strong revenue growth, attractive valuation, and management's optimistic 2027 outlook. Despite recent earnings volatility, AENT's reven

Takeda Pharmaceutical Company Limited (TAK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript